These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 33920896

  • 1. Compound Haplotype Variants in CFH and CD46 Genes Determine Clinical Outcome of Atypical Hemolytic Uremic Syndrome (aHUS)-A Series of Cases from a Single Family.
    Furmańczyk-Zawiska A, Kubiak-Dydo A, Użarowska-Gąska E, Kotlarek-Łysakowska M, Salata K, Kolanowska M, Świerniak M, Gaj P, Leszczyńska B, Daniel M, Jażdżewski K, Durlik M, Wójcicka A.
    J Pers Med; 2021 Apr 15; 11(4):. PubMed ID: 33920896
    [Abstract] [Full Text] [Related]

  • 2.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Noris M, Bresin E, Mele C, Remuzzi G.
    ; 1993 Apr 15. PubMed ID: 20301541
    [Abstract] [Full Text] [Related]

  • 3. Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant.
    Piras R, Iatropoulos P, Bresin E, Todeschini M, Gastoldi S, Valoti E, Alberti M, Mele C, Galbusera M, Cuccarolo P, Benigni A, Remuzzi G, Noris M.
    Front Med (Lausanne); 2020 Apr 15; 7():579418. PubMed ID: 33224962
    [Abstract] [Full Text] [Related]

  • 4. CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome.
    Piras R, Valoti E, Alberti M, Bresin E, Mele C, Breno M, Liguori L, Donadelli R, Rigoldi M, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2022 Apr 15; 13():1011580. PubMed ID: 36793547
    [Abstract] [Full Text] [Related]

  • 5. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.
    Rev Med Interne; 2011 Apr 15; 32(4):232-40. PubMed ID: 21376430
    [Abstract] [Full Text] [Related]

  • 6. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L, Nester CM, Reed AI, Zhang Y, Smith RJ, Thomas CP.
    Transplant Proc; 2012 Dec 15; 44(10):3037-40. PubMed ID: 23195022
    [Abstract] [Full Text] [Related]

  • 7. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
    Richards A, Kathryn Liszewski M, Kavanagh D, Fang CJ, Moulton E, Fremeaux-Bacchi V, Remuzzi G, Noris M, Goodship TH, Atkinson JP.
    Mol Immunol; 2007 Jan 15; 44(1-3):111-22. PubMed ID: 16882452
    [Abstract] [Full Text] [Related]

  • 8. Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.
    Kim S, Park E, Min SI, Yi NJ, Ha J, Ha IS, Cheong HI, Kang HG.
    J Korean Med Sci; 2018 Jan 01; 33(1):e4. PubMed ID: 29215813
    [Abstract] [Full Text] [Related]

  • 9. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
    Walsh PR, Johnson S, Brocklebank V, Salvatore J, Christian M, Kavanagh D.
    Am J Kidney Dis; 2018 Feb 01; 71(2):287-290. PubMed ID: 29248304
    [Abstract] [Full Text] [Related]

  • 10. Blockade of the Terminal Complement Cascade Using Ravulizumab in a Pediatric Patient With Anti-complement Factor H Autoantibody-Associated aHUS: A Case Report and Literature Review.
    Wu X, Szarzanowicz A, Garba A, Schaefer B, Waz WR.
    Cureus; 2021 Nov 01; 13(11):e19476. PubMed ID: 34912617
    [Abstract] [Full Text] [Related]

  • 11. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
    Vondrák K, Seeman T.
    Transplant Proc; 2018 Apr 01; 50(3):967-970. PubMed ID: 29661469
    [Abstract] [Full Text] [Related]

  • 12. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P, Dickenmann M, Schifferli JA.
    Nephron Clin Pract; 2010 Apr 01; 114(4):c219-35. PubMed ID: 20090363
    [Abstract] [Full Text] [Related]

  • 13. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
    Mohlin FC, Nilsson SC, Levart TK, Golubovic E, Rusai K, Müller-Sacherer T, Arbeiter K, Pállinger É, Szarvas N, Csuka D, Szilágyi Á, Villoutreix BO, Prohászka Z, Blom AM.
    Mol Immunol; 2015 Jun 01; 65(2):367-76. PubMed ID: 25733390
    [Abstract] [Full Text] [Related]

  • 14. Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutation.
    Wang C, Chen J, Han X, Sun M, Fang X, Zhai Y, Miao Q, Zhang Z, Tang X, Liu J, Shen Q, Xu H.
    Pediatr Nephrol; 2024 Dec 01; 39(12):3513-3520. PubMed ID: 39097532
    [Abstract] [Full Text] [Related]

  • 15. Deleterious Impact of a Novel CFH Splice Site Variant in Atypical Hemolytic Uremic Syndrome.
    Schönauer R, Seidel A, Grohmann M, Lindner TH, Bergmann C, Halbritter J.
    Front Genet; 2019 Dec 01; 10():465. PubMed ID: 31156713
    [Abstract] [Full Text] [Related]

  • 16. Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome.
    Yun JW, Oh J, Lee KO, Lee SJ, Kim JO, Kim NK, Kim JS, Koh Y, Yoon SS, Yhim HY, Jo SK, Park Y, Lee JE, Park J, Lee JW, Kim SH, Kim HJ, Oh D, Korean TTP Registry investigators, aHUS working group.
    Thromb Res; 2020 Oct 01; 194():45-53. PubMed ID: 33213850
    [Abstract] [Full Text] [Related]

  • 17. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E, Alberti M, Iatropoulos P, Piras R, Mele C, Breno M, Cremaschi A, Bresin E, Donadelli R, Alizzi S, Amoroso A, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2019 Oct 01; 10():853. PubMed ID: 31118930
    [Abstract] [Full Text] [Related]

  • 18. Favorable long-term outcomes of isolated liver transplantation in a child with atypical hemolytic uremic syndrome caused by a novel complement factor H mutation
.
    Cho H, Lee Y.
    Clin Nephrol; 2017 Jul 01; 88(1):52-56. PubMed ID: 28502324
    [Abstract] [Full Text] [Related]

  • 19. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C, Verhave JC, Berger SP, van de Kar NCAJ, Wetzels JFM.
    Am J Kidney Dis; 2017 Dec 01; 70(6):770-777. PubMed ID: 28821363
    [Abstract] [Full Text] [Related]

  • 20. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
    Fremeaux-Bacchi V, Moulton EA, Kavanagh D, Dragon-Durey MA, Blouin J, Caudy A, Arzouk N, Cleper R, Francois M, Guest G, Pourrat J, Seligman R, Fridman WH, Loirat C, Atkinson JP.
    J Am Soc Nephrol; 2006 Jul 01; 17(7):2017-25. PubMed ID: 16762990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.